Methylphenidate-Prodrugs, Processes of Making and Using the Same
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 9 of these applications claim priority to application PCT/US2017/065482, filed Dec 9, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,505,537 | Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same In force · Low confidence | Commave Therapeutics S.A. | In force | Low confidence | ||
| US 10,584,112 | Methylphenidate-Prodrugs, Processes of Making and Using the Same In force · Low confidence | Commave Therapeutics S.A. | In force | Low confidence | ||
| US 10,584,113 | Methylphenidate-Prodrugs, Processes of Making and Using the Same In force · Low confidence | Commave Therapeutics S.A. | In force | Low confidence | ||
| US 10,759,778 | Methylphenidate-Prodrugs, Processes of Making and Using the Same In force · Low confidence | Commave Therapeutics S.A. | In force | Low confidence | ||
| US 10,858,341 | Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same In force · Low confidence | Commave Therapeutics S.A. | In force | Low confidence | ||
| US 10,954,212 | Compositions Comprising Methlphenidate-Prodrugs, Processes of Making and Using the Same In force · Low confidence | Commave Therapeutics S.A. | In force | Low confidence | ||
| US 10,954,213 | Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same In force · Low confidence | Commave Therapeutics S.A. | In force | Low confidence | ||
| US 11,021,459 | Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same In force · Low confidence | Commave Therapeutics S.A. | In force | Low confidence | ||
| US 11,021,460 | Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same In force · Low confidence | Commave Therapeutics S.A. | In force | Low confidence | ||
| Application 17/240,181 | Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same Abandoned Abandoned Mar 28, 2023 | Commave Therapeutics S.A. | Abandoned | Abandoned Mar 28, 2023 |
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
9 of these are in force and held by Commave Therapeutics S.A..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.